Classes
- OS - Difficult-to-treat asthma +1DV01068 | Second Faculty of Medicine
- OS - Bronchology +1DV01070 | Second Faculty of Medicine
- OS - Cystic fibrosis in adults +1DV01071 | Second Faculty of Medicine
- OS - Lung function testingDV01072 | Second Faculty of Medicine
- OS - Treatment for tobacco addictionDV01073 | Second Faculty of Medicine
- OS - Outpatient practice in pneumology +1DV01126 | Second Faculty of Medicine
- OS - Epidemiology in pneumology +1DV01127 | Second Faculty of Medicine
- OS - Sleep-disordered breathing +1DV01128 | Second Faculty of Medicine
- OS - Selection of lung transplant candidates +1DV01147 | Second Faculty of Medicine
- OS - New procedures in lung cancer +1DV01210 | Second Faculty of Medicine
Publications
- News in the care of patients with pleural effusions2011 | Second Faculty of Medicine
- Pleural effusion2008 | Second Faculty of Medicine
- Pleural effusions2007 | Second Faculty of Medicine
- Pleural disease2006 | Second Faculty of Medicine
- Pleural effusions in the pulmonary department of an University Hospital in 19981999 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- Monitoring of ECFS quality standards for the clinical management of adults with cystic fibrosis2024 | Second Faculty of Medicine
- Effect of SARS-CoV-2 infection on anti-HLA antibodies and de novo donor specific antibodies incidence in lung transplant recipients2023 | Second Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University
- Elexacaftor-tezacaftor-ivacaftor in patients with cystic fibrosis ineligible for clinical trials: a 24-week observational study2023 | Second Faculty of Medicine
- K životnímu jubileu prof. MUDr. Miloslava Marela, CSc.2023 | Second Faculty of Medicine
- Significance of plasma fibrinogen and malondialdehyde in the post-inflammatory period in patients with cystic fibrosis2022 | Second Faculty of Medicine, First Faculty of Medicine
Loading network view...